Point72 (Difc) LTD Mirum Pharmaceuticals, Inc. Transaction History
Point72 (Difc) LTD
- $3.17 Trillion
- Q1 2024
A detailed history of Point72 (Difc) LTD transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 2,721 shares of MIRM stock, worth $92,187. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,721Holding current value
$92,187% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
184Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$220 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$148 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$112 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$95.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$93.8 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.25B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...